MicroRNA‐124‐3p regulates cell proliferation, invasion, apoptosis, and bioenergetics by targeting PIM1 in astrocytoma
暂无分享,去创建一个
Feng Zhi | Lei Wang | Qiang Wang | Yilin Yang | Yilin Yang | Xiwei Xia | Naiyuan Shao | Danni Deng | Yao Chen | Bowen Li | Lian Xue | Lian Xue | F. Zhi | Lei Wang | Bowen Li | N. Shao | Yao Chen | Danni Deng | X. Xia | Qiang Wang
[1] Jianxin Sun,et al. Pim1 kinase promotes angiogenesis through phosphorylation of endothelial nitric oxide synthase at Ser-633. , 2016, Cardiovascular research.
[2] Yiqun Cao,et al. Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM , 2013, BMC Cancer.
[3] A. Kraft,et al. PIM1 Protein Kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells , 2009, Cancer biology & therapy.
[4] Xi Chen,et al. The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma. , 2010, European journal of cancer.
[5] Charles Duyckaerts,et al. The 2007 WHO classification of tumors of the central nervous system – what has changed? , 2008, Current opinion in neurology.
[6] Erwin G. Van Meir,et al. Exciting New Advances in Neuro‐Oncology: The Avenue to a Cure for Malignant Glioma , 2010, CA: a cancer journal for clinicians.
[7] Lizhuang Yang,et al. MiR-124 inhibits the growth of glioblastoma through the downregulation of SOS1. , 2013, Molecular medicine reports.
[8] F. Arenas-Huertero,et al. Reductions in the expression of miR-124-3p, miR-128-1, and miR-221-3p in pediatric astrocytomas are related to high-grade supratentorial, and recurrent tumors in Mexican children , 2014, Child's Nervous System.
[9] F. Slack,et al. Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.
[10] W. Sellers,et al. TSC 2 regulates VEGF through mTOR-dependent and-independent pathways , 2003 .
[11] Xingjun Jiang,et al. miR-124a restoration inhibits glioma cell proliferation and invasion by suppressing IQGAP1 and β-catenin. , 2014, Oncology reports.
[12] Andrea Sottoriva,et al. The shaping and functional consequences of the microRNA landscape in breast cancer , 2013, Nature.
[13] C. Bieberich,et al. Stabilization of the prostate‐specific tumor suppressor NKX3.1 by the oncogenic protein kinase Pim‐1 in prostate cancer cells , 2013, Journal of cellular biochemistry.
[14] Anton J. Enright,et al. Human MicroRNA Targets , 2004, PLoS biology.
[15] C. Burge,et al. Prediction of Mammalian MicroRNA Targets , 2003, Cell.
[16] Xiaohong Wang,et al. MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells , 2014, Tumor Biology.
[17] C. Harris,et al. Genetic variation in microRNA networks: the implications for cancer research , 2010, Nature Reviews Cancer.
[18] Yilin Yang,et al. miR-106a-5p Inhibits the Proliferation and Migration of Astrocytoma Cells and Promotes Apoptosis by Targeting FASTK , 2013, PloS one.
[19] Chuan Jin,et al. CDA-2 induces cell differentiation through suppressing Twist/SLUG signaling via miR-124 in glioma , 2012, Journal of Neuro-Oncology.
[20] M. Esteller. Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.
[21] D. Su,et al. An updated role of microRNA-124 in central nervous system disorders: a review , 2015, Front. Cell. Neurosci..
[22] S. Green,et al. GliaSite Brachytherapy for Treatment of Recurrent Malignant Gliomas: A Retrospective Multi-institutional Analysis , 2006, Neurosurgery.
[23] William R Sellers,et al. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. , 2003, Cancer cell.
[24] M. Minden,et al. The Pim-1 Protein Kinase Is an Important Regulator of MET Receptor Tyrosine Kinase Levels and Signaling , 2014, Molecular and Cellular Biology.
[25] A. Minn,et al. MicroRNA-124 expression counteracts pro-survival stress responses in glioblastoma , 2014, Oncogene.
[26] J. Ai,et al. miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells. , 2013, Cancer letters.
[27] T. Jiang,et al. MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras. , 2014, Neuro-oncology.
[28] D. Gutsch,et al. The proto-oncogene Pim-1 is a target of miR-33a , 2012, Oncogene.
[29] Yi Huang,et al. miR-495 Mediates Metabolic Shift in Glioma Cells via Targeting Glut1 , 2015, The Journal of craniofacial surgery.
[30] L. Kopper,et al. Tumor stem cells , 2008, Pathology & Oncology Research.
[31] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[32] S. Knapp,et al. PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma , 2012, British Journal of Cancer.
[33] Kye-Seong Kim,et al. miR‐124a Is Important for Migratory Cell Fate Transition During Gastrulation of Human Embryonic Stem Cells , 2010, Stem cells.
[34] I. Ng,et al. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma , 2015, Oncotarget.
[35] Santosh Kesari,et al. Malignant gliomas in adults. , 2008, The New England journal of medicine.
[36] Carmen Blanco-Aparicio,et al. The PIM Family of Serine/Threonine Kinases in Cancer , 2014, Medicinal research reviews.
[37] Michael C. Ostrowski,et al. MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. , 2010, Molecular cell.
[38] Wei-hua Zhao,et al. Downregulation of miR-124 promotes the growth and invasiveness of glioblastoma cells involving upregulation of PPP1R13L. , 2013, International journal of molecular medicine.
[39] Arto Mannermaa,et al. Proto-oncogene PIM-1 is a novel estrogen receptor target associating with high grade breast tumors , 2013, Molecular and Cellular Endocrinology.
[40] Claudia Petritsch,et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells , 2008 .
[41] P. Ward,et al. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.
[42] T. Liang,et al. Gap Junctions Enhance the Antiproliferative Effect of MicroRNA‐124‐3p in Glioblastoma Cells , 2015, Journal of cellular physiology.
[43] Bin Xu,et al. miR‐124 exerts tumor suppressive functions on the cell proliferation, motility and angiogenesis of bladder cancer by fine‐tuning UHRF1 , 2015, The FEBS journal.
[44] Teng Chen,et al. Downregulation of microRNA-124 predicts poor prognosis in glioma patients , 2014, Neurological Sciences.
[45] L. You,et al. PIM kinases: an overview in tumors and recent advances in pancreatic cancer. , 2014, Future oncology.
[46] Gang Lu,et al. Loss of Brain-enriched miR-124 MicroRNA Enhances Stem-like Traits and Invasiveness of Glioma Cells* , 2012, The Journal of Biological Chemistry.
[47] Yan Zhu,et al. Activated β-catenin Forces N2A Cell-derived Neurons Back to Tumor-like Neuroblasts and Positively Correlates with a Risk for Human Neuroblastoma , 2012, International journal of biological sciences.
[48] Ru-jia Li,et al. Inhibition of Pim-1 attenuates the proliferation and migration in nasopharyngeal carcinoma cells. , 2012, Asian Pacific journal of tropical medicine.
[49] Y. Guan,et al. microRNA-124 Inhibits Migration and Invasion by Down-Regulating ROCK1 in Glioma , 2013, PloS one.
[50] X. Wang,et al. Role of micro-RNA (miRNA) in pathogenesis of glioblastoma. , 2015, European review for medical and pharmacological sciences.
[51] Jian Sun,et al. MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas , 2014, Diagnostic Pathology.
[52] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[53] Yilin Yang,et al. MiR-181b-5p Downregulates NOVA1 to Suppress Proliferation, Migration and Invasion and Promote Apoptosis in Astrocytoma , 2014, PloS one.
[54] Y. Mao,et al. miR-124 suppresses the migration and invasion of glioma cells in vitro via Capn4. , 2016, Oncology reports.
[55] Wanyeon Kim,et al. PIM1 kinase inhibitors induce radiosensitization in non-small cell lung cancer cells. , 2013, Pharmacological research.